NEW ORLEANS - Ochsner Health System has received a research grant from the National Institutes of Health awarded to Dr. Yong Sung Choi, MD, for research in B Cell Lymphoma Therapy for cancer patients. The grant will be for $1.6 million over the next five years. Dr. Choi's research is designed to gain a better perceptive on this new therapy.
"B-cells, a type of lymphocyte, defend the body against bacterial infection and other illness, explains Dr. Choi. "These cells can become malignant and, in this state of uncontrolled growth, form tumors that enlarge the lymph nodes or other areas of the lymphatic system." B-cell lymphoma is one of the most common types of lymphoma and with this funding we will further our understanding of the disease and lead to improved therapies for this type of cancer patient.
This NIH project is supported by Grant Number R01CA121039 from the NCI. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCI or NIH.
Ochsner Health System (www.ochsner.org) is a non-profit, academic, multi-specialty, healthcare delivery system dedicated to patient care, research and education. The system includes seven hospitals, a sub-acute facility, and 33 health centers located throughout Southeast Louisiana. Through our unique coordinated system, Ochsner provides healthcare with peace of mind because we put the needs of all patients first. Ochsner employs over 600 physicians in 80 medical specialties and subspecialties and conducts over 700 ongoing clinical research trials annually. Ochsner was ranked #1"Best Place to Work" by New Orleans CityBusiness Magazine in 2005 and 2006 and received the Consumer Choice for Healthcare in New Orleans for 12 consecutive years. Ochsner was ranked as "Best" Hospital by U.S. News and World Report in July 2007.